---
title: "Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290603458.md"
description: "Atrium Therapeutics granted inducement equity awards to eight newly hired non-executive employees on June 20. The package includes 66,000 non-qualified stock options with an exercise price of $12.66 and 33,000 restricted stock units. Options vest 25% at year one then monthly over three years, while RSUs vest 25% at year one then annually over three years."
datetime: "2026-06-23T20:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290603458.md)
  - [en](https://longbridge.com/en/news/290603458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290603458.md)
---

# Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66

-   Atrium Therapeutics granted inducement equity awards to eight newly hired non-executive employees on June 20. \* Package totals 66,000 non-qualified stock options, exercise price USD 12.66, with 25% vesting at year one then monthly over three years. \* Also issued 33,000 restricted stock units, with 25% vesting at year one then annually over three years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA90548) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [RNA.US](https://longbridge.com/en/quote/RNA.US.md)

## Related News & Research

- [Dear Coherent Stock Fans, Mark Your Calendars for August 12](https://longbridge.com/en/news/294984789.md)
- [Candel Therapeutics grants inducement stock options for 30,800 shares at $10.01 each](https://longbridge.com/en/news/294731432.md)
- [Palvella Therapeutics CEO joins Canaccord Genuity Growth Conference fireside chat](https://longbridge.com/en/news/294958978.md)
- [Kalaris Therapeutics director Laurie Keating files initial beneficial ownership statement](https://longbridge.com/en/news/294731013.md)
- [Maplight Therapeutics CSO Lillie James Woodruff sells 22,082 shares for $276,908.28](https://longbridge.com/en/news/294889583.md)